Search

Your search keyword '"Filippi, Jérome"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Filippi, Jérome" Remove constraint Author: "Filippi, Jérome"
67 results on '"Filippi, Jérome"'

Search Results

2. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

3. Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID

4. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

5. Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial

6. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study

7. Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study

8. Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine

9. Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn’s Disease

10. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

11. Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus

12. Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

13. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

14. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

16. High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

17. Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

19. Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

20. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

23. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

24. Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn’s Disease Using Magnetic Resonance Enterography

25. Development of a New Index to Assess Small Bowel Inflammation Severity in Crohn’s Disease Using Magnetic Resonance Enterography

26. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

28. Mo1565: EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

30. Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

31. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

32. 457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY

33. 946 DEEP REMISSION AT 1 YEAR IS NOT ASSOCIATED WITH BETTER OUTCOME IN CROHN'S DISEASE: LONG-TERM DATA FROM TAILORIX

35. Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease

36. 569 – Adalimumab for Patients with Crohn's Disease Complicated by Intra-Abdominal Abscess: A Multicenter Prospective, Observational Cohort Study

37. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.

38. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

40. Mo1785 - Long-Term Outcome of Crohn's Disease Complicated by Upper Gastrointestinal Stricture: A Getaid Cohort Study

41. Su1798 - Comparison Between Faecal Chitinase 3-Like 1, Matrix Metalloprotease 9 and Calprotectin to Assess Mucosal Healing in Patients with Crohn's Disease: A Multicenter Prospective Study

43. Sa1927 - Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid

45. Tu1940 Patients' Point of View Regarding Acceptability and Usefulness of Inflammatory Bowel Diseases Monitoring Tools: Results From a Nationwide Multicenter Study (the ACCEPT Study)

46. Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study

47. 692 Drug-Level Based Dosing Versus Symptom-Based Dose Adaptation in Patients With Crohn's Disease: A Prospective, Randomized Multicenter Study (TAILORIX)

48. 385 Impact of an Education Program on IBD Patient's Skills: One Year Results of the ECIPE Randomized, Controlled Multicenter Study

49. 745 Methotrexate for Corticosteroid-Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial

Catalog

Books, media, physical & digital resources